Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia

J Clin Immunol. 2010 Jan;30(1):121-31. doi: 10.1007/s10875-009-9341-5. Epub 2009 Nov 11.

Abstract

Introduction: X-linked agammagobulinemia (XLA) is a primary immunodeficiency disorder caused by Bruton's tyrosine kinase (Btk) gene mutation. Recent studies suggested genotype-phenotype correlation in XLA, but a definitive association remains controversial.

Patients and methods: We examined the relationship between specific Btk gene mutations and severity of clinical presentation in 62 patients with XLA. Disease severity was assessed by the age of disease onset and the presence of severe infections, while mutations were classified into severe and mild based on structural and functional consequence by bioinformatics analysis.

Results: Fifty-six Btk mutations were identified in 62 patients from 57 kindreds. Variation in phenotypes was observed, and there was a tendency of association between genotype and age of disease onset as well as occurrence of severe infections.

Conclusion: A critical analysis of the circumstances upon presentation also revealed that under-recognition of recurrent infections and relevant family history are important hurdles to timely diagnosis of XLA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Agammaglobulinemia
  • Age of Onset
  • Child
  • Child, Preschool
  • China
  • DNA Mutational Analysis
  • Disease Progression
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Infections / diagnosis
  • Infections / epidemiology
  • Infections / genetics*
  • Infections / physiopathology
  • Male
  • Mutation / genetics
  • Polymorphism, Genetic
  • Protein-Tyrosine Kinases / genetics*
  • Protein-Tyrosine Kinases / immunology
  • X-Linked Combined Immunodeficiency Diseases / diagnosis
  • X-Linked Combined Immunodeficiency Diseases / epidemiology
  • X-Linked Combined Immunodeficiency Diseases / genetics*
  • X-Linked Combined Immunodeficiency Diseases / physiopathology

Substances

  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human